Buscar
Mostrando ítems 1-10 de 325
Effectiveness of oral hypoglycemic drugs in the metabolic control of patients with gestational diabetes Eficacia de los hipoglicemiantes orales en el control metabólico de pacientes con diabetes mellitus gestacional
(2008)
Gestational Diabetes is characterized by different degrees of glucose intolerance that produce a series of fetal and perinatal alterations. During many years, in those cases of gestational diabetes that did not respond to ...
Eficacia de los hipoglicemiantes orales en el control metabólico de pacientes con diabetes mellitus gestacional
(Sociedad Médica de Santiago, 2008)
Diabetes Mellitus tipo 2 con tendencia a la cetosis. Caso clínico
(Sociedad Médica de Santiago, 2015)
Ketosis prone type 2 diabetes (KPD) is presently a well-defined clinical entity,
characterized by a debut with severe hyperglycemia and ketoacidosis similar to
the presenting form of Type 1 diabetes mellitus (DM1). ...
Role of magnesium in the efficacy of hypoglycemic agentsRol del Magnesio en la Eficacia de Fármacos Hipoglicemiantes
(Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana, 1995)
Evaluación del perfil de eficacia y seguridad de vildagliptina en vida real de pacientes chilenos con diabetes mellitus tipo 2
(Sociedad Médica de Santiago, 2015)
Background: Vildagliptin is a dipeptidyl peptidase IV inhibitor (DPP4i). Its
efficacy and safety of DPP4i in Chilean real life type 2 diabetic (T2D) patients is
not well known. Aim: To assess the safety profile and ...
Safety and efficacy of vildagliptin in real life chilean diabetic patients Evaluación del perfil de eficacia y seguridad de vildagliptina en vida real de pacientes chilenos con diabetes mellitus tipo 2
(Sociedad Medica de Santiago, 2015)
© 2015, Sociedad Medica de Santiago. All rights reserved. Background: Vildagliptin is a dipeptidyl peptidase IV inhibitor (DPP4i). Its efficacy and safety of DPP4i in Chilean real life type 2 diabetic (T2D) patients is not ...
Evaluación del perfil de eficacia y seguridad de vildagliptina en vida real de pacientes chilenos con diabetes mellitus tipo 2
(Soc. Médica de Santiago, 2015)
Background: Vildagliptin is a dipeptidyl peptidase IV inhibitor (DPP4i). Its efficacy and safety of DPP4i in Chilean real life type 2 diabetic (T2D) patients is not well known. Aim: To assess the safety profile and ...